Overview
Tracy Rose is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Rose is rated as an Experienced provider by MediFind in the treatment of Teratoma of the Mediastinum. Her top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Adrenal Cancer, Nephrectomy, and Tissue Biopsy. Dr. Rose is currently accepting new patients.
Her clinical research consists of co-authoring 63 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
University Of North Carolina At Chapel Hill
Matthew Milowsky is an Oncologist and a Hematologist in Chapel Hill, North Carolina. Dr. Milowsky is rated as an Elite provider by MediFind in the treatment of Teratoma of the Mediastinum. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Tissue Biopsy. Dr. Milowsky is currently accepting new patients.
Duke Cancer Center
My goals are to develop and provide treatments that prolong and improve quality of the lives of patients with aggressive prostate, kidney, bladder, and testicular cancer. This work involves the direct care of patients in the clinic and clinical research involving the development of new therapies in clinical trials. I devote over half of my time to understanding how prostate cancer spreads and resists therapies, as well as methods of measuring this biology in patients, which may lead to improved therapies designed to block this process. Outside of work, I have a busy family life with three children, and a wife who is a Duke pediatrician. I enjoy playing soccer and hiking. Dr. Armstrong is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes.
Duke Cancer Center Cary
I mainly treat patients with genitourinary cancers including prostate, kidney, bladder, testicular and penile cancer. My goal is to be attentive and devoted to my patients who are often dealing with complicated health problems. I try to personalize my care because every patient is different. I believe the future is promising because new treatments are being discovered every day. I am involved in clinical trials done through Duke University. Clinical trials are designed to provide patients with access to the newest possible treatments. I am also part of our multi-disciplinary cancer team including urologic oncologists, geneticists, radiation oncologists, pathologists, radiologists, and other specialists. I grew up in Cary and did all of my medical training in the Research Triangle Park area. I feel honored to practice in the same community I have lived in for more than twenty-five years. Dr. Ramalingam is rated as a Distinguished provider by MediFind in the treatment of Teratoma of the Mediastinum. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, and Prostatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adrenal CancerDr. Rose isDistinguished. Learn about Adrenal Cancer.
- Bladder CancerDr. Rose isDistinguished. Learn about Bladder Cancer.
- Prostate CancerDr. Rose isDistinguished. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Rose isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Urothelial CancerDr. Rose isDistinguished. Learn about Urothelial Cancer.
- Advanced
- Adrenocortical CarcinomaDr. Rose isAdvanced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Rose isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell Carcinoma
- Clear Cell SarcomaDr. Rose isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Rose isAdvanced. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Rose isAdvanced. Learn about Familial Wilms Tumor 2.
- Experienced
- ChoriocarcinomaDr. Rose isExperienced. Learn about Choriocarcinoma.
- Hereditary NeuroblastomaDr. Rose isExperienced. Learn about Hereditary Neuroblastoma.
- Hypothalamic HamartomasDr. Rose isExperienced. Learn about Hypothalamic Hamartomas.
- Inflammatory Myofibroblastic TumorDr. Rose isExperienced. Learn about Inflammatory Myofibroblastic Tumor.
- Mediastinal TumorDr. Rose isExperienced. Learn about Mediastinal Tumor.
- MelanomaDr. Rose isExperienced. Learn about Melanoma.

